dc.contributor.author | Andy, Camille | eng |
dc.contributor.author | Flake, Donna | eng |
dc.date.issued | 2005 | eng |
dc.description.abstract | Short-term use of metformin (Glucophage) improves ovulation rates for women with polycystic ovary syndrome (PCOS) (strength of recommendation [SOR]: A, based on systematic reviews of randomized controlled trials [RCT]). Metformin also decreases menstrual irregularities (SOR: B, extrapolated from a systematic review). When added to clomiphene, metformin increases ovulation and pregnancy rates when compared with clomiphene alone (SOR: A, systematic review). Thiazolidinediones (TZDs) improve ovulation rates as well (SOR: B, based on low-quality RCTs). Research of longer duration including the key outcomes of pregnancy and birth rates, is needed to clarify the appropriate use of insulin-sensitizing drugs for PCOS. | eng |
dc.identifier.uri | http://hdl.handle.net/10355/3285 | eng |
dc.language | English | eng |
dc.publisher | Family Physicians Inquiries Network | eng |
dc.relation.ispartofcollection | Clinical Inquiries, 2005 (MU) | eng |
dc.relation.ispartofcommunity | University of Missouri--Columbia. School of Medicine. Department of Family and Community Medicine. Family Physicians Inquiries Network | eng |
dc.relation.ispartofseries | Journal of family practice, 54, no. 02 (February 2005): 156+. | eng |
dc.rights | OpenAccess. | eng |
dc.rights.license | This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 License. | eng |
dc.subject | birth rate | eng |
dc.subject | polycystic ovary syndrome | eng |
dc.subject | pregnancy rate | eng |
dc.subject | menstruation | eng |
dc.subject.lcsh | Polycystic Ovary Syndrome | eng |
dc.subject.mesh | Thiazolidinediones -- therapeutic use | eng |
dc.title | Do insulin-sensitizing drugs increase ovulation rates for women with PCOS? | eng |
dc.type | Article | eng |